Abstract:Following the global-level Ebola virus disease (EVD) outbreak during 2014–2016, international collaboration with multiorganizational participation has rapidly increased. Given the greater priorities for research and development (R&D) outcomes despite the quantitative and qualitative lack of high-containment laboratory facilities in low- and middle-income countries (LMICs), where biological targets for investigation are located near their natural habitats, occupational readiness for health workers' safety has not been well-addressed, where limited global expert human resources are being deployed to high-containment laboratories including biosafety level 4 (BSL-4) facilities for case management and medical investigations. Pursuing scientific and managerial success to make laboratories efficient and productive, most laboratory safety policies have focused on the functionality of technical skills or performance, procedural methodologies, and supervision over the employees to collaborate in LMICs. The experts dispatched from advanced countries bring a long list of scientific tasks with high-tech devices, supplies, and training programs to introduce their collaboration with local partners in LMICs. However, the dispatched experts would subsequently realize their list becomes endless to establish their basic functions required in high-containment laboratories to ensure qualified scientific outcomes in LMICs. Under such circumstances where dual or multiple policies and standards accommodated pose dilemmas for operational procedures to ensure biosafety and biosecurity, all the frontline experts from both LMICs and advanced countries may be exposed to significant risks of life-threating infection of highly pathogenic agents like EVD, without any pragmatic measures or road maps to establish valued international collaboration, pursuing its sustainability. Given the fact mentioned above, we conducted a quick review of the key biosafety and biosecurity management documents, relevant policy analyses, and research to understand the current status and, if any, measures to dissolve critical dilemmas mentioned above. As a result, we found that occupational safety and health (OSH) aspects had not been sufficiently addressed, particularly in the context of international BSL-4 collaboration in LMICs. Moreover, consideration of OSH can be one of the key drivers to make such collaborative interventions more pragmatic, safer to reorient, harness disease-based vertical approaches, and harmonize policies of biosafety and biosecurity, particularly for collaborations organized in resource-limited settings.

Facility design and management. Strategies for high level biocontainment

New technique: Development of a large-scale isolation chamber system for the safe and humane care of medium-sized laboratory animals harboring infectious diseases

Design and Husbandry Considerations for a Containment Level 2 Aquatic Facility

The Endurance Testing Process: A Methodology to Verify the Functionality of Biocontainment, Security, and Life Safety Systems in BSL-3 and BSL-4 Laboratories

Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities

Studies of Transgenic Mosquitoes in Disease-Endemic Countries: Preparation of Containment Facilities

Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health

Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks

Features of Keeping Laboratory Animals Infected with Pathogenic Biological Agents, Pathogenicity Group I–II, under Experiment

The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories

We need a global framework for promoting safe handling of high consequence pathogens

Current status and future challenges of high-level biosafety laboratories in China

Creating effective biocontainment facilities and maintenance protocols for raising specific pathogen-free, severe combined immunodeficient (SCID) pigs

Current status of pathogen handling in European laboratories: focus on viral inactivation process

Accepting Higher Morbidity in Exchange for Sacrificing Fewer Animals in Studies Developing Novel Infection-Control Strategies

Management of zoonoses in research institutions – lessons learned from a Coxiella burnetii outbreak case

Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility

Lessons Learned from the Design, Construction, and Commissioning of a Retrofitted Arthropod Containment Level 3 Insectary

Potential Strategies and Biosafety Protocols Used for Dual‐use Research on Highly Pathogenic Influenza Viruses

Xenobiology for the Biocontainment of Synthetic Organisms: Opportunities and Challenges

Biosafety and Biosecurity: A Relative Risk-Based Framework for Safer, More Secure, and Sustainable Laboratory Capacity Building